- Company Directors - W
- Wolynic Edward T
Insider Trading History of Wolynic Edward T
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Wolynic Edward T since 2006.
The trader's CIK number is 1326727.
At the time of the last reporting, Wolynic Edward T was the Director of Immunomedics Inc. (stock ticker symbol IMMU).
Also see all insider trading activities at Immunomedics Inc.
Note that in the past
Wolynic Edward T also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Engelhard Corp (EC) by Wolynic Edward T
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | EC | 0 | $0 | 18,475 | $711,287 | 18,475 | $356,031 |
Yearly summary of insider trading at Immunomedics Inc (IMMU) by Wolynic Edward T
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | IMMU | 0 | $0 | 0 | $0 | 5,000 | $0 |
| 2008 | IMMU | 0 | $0 | 0 | $0 | 5,000 | $0 |
Insider trading activities at 2 companies by Wolynic Edward T:
1. Engelhard Corp (EC)
2. Immunomedics Inc (IMMU)
Table 1. Insider trading of Engelhard Corp (EC) by Wolynic Edward T
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-01-03 | EC | Sale | 18,475 | 38.50 | 711,287 |
| 2006-01-03 | EC | Option Ex | 18,475 | 19.27 | 356,031 |
Table 2. Insider trading of Immunomedics Inc (IMMU) by Wolynic Edward T
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-12-02 | IMMU | Option Ex | 5,000 | .00 | 0 |
| 2008-12-03 | IMMU | Option Ex | 5,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Wolynic Edward T
(Director of Immunomedics Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.